Metropolitan Life Insurance Co. NY Has $387,000 Position in Axcelis Technologies, Inc. (ACLS)

Metropolitan Life Insurance Co. NY continued to hold its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) during the first quarter, Holdings Channel reports. The institutional investor owned 20,593 shares of the semiconductor company’s stock at the end of the first quarter. Metropolitan Life Insurance Co. NY’s holdings in Axcelis Technologies were worth $387,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in the stock. State Street Corp increased its stake in shares of Axcelis Technologies by 4.4% in the fourth quarter. State Street Corp now owns 495,084 shares of the semiconductor company’s stock valued at $7,205,000 after buying an additional 20,751 shares during the period. Norges Bank purchased a new stake in shares of Axcelis Technologies during the fourth quarter valued at about $2,082,000. Teachers Advisors LLC increased its stake in shares of Axcelis Technologies by 4.0% in the fourth quarter. Teachers Advisors LLC now owns 46,666 shares of the semiconductor company’s stock valued at $679,000 after buying an additional 1,786 shares during the period. Russell Investments Group Ltd. purchased a new stake in shares of Axcelis Technologies during the first quarter valued at about $875,000. Finally, Bank of New York Mellon Corp increased its stake in shares of Axcelis Technologies by 36.9% in the first quarter. Bank of New York Mellon Corp now owns 163,130 shares of the semiconductor company’s stock valued at $3,067,000 after buying an additional 43,934 shares during the period. 73.73% of the stock is currently owned by institutional investors.

Axcelis Technologies, Inc. (NASDAQ ACLS) traded up 3.54% during mid-day trading on Friday, hitting $20.50. 100,982 shares of the stock traded hands. Axcelis Technologies, Inc. has a 52 week low of $11.05 and a 52 week high of $26.52. The firm has a market cap of $640.07 million, a P/E ratio of 22.00 and a beta of 1.11. The firm’s 50-day moving average price is $21.71 and its 200-day moving average price is $19.64.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings results on Thursday, August 3rd. The semiconductor company reported $0.33 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.34 by $0.01. Axcelis Technologies had a return on equity of 12.52% and a net margin of 9.10%. The firm had revenue of $102.80 million for the quarter, compared to the consensus estimate of $100.07 million. During the same period last year, the company posted $0.10 EPS. The business’s revenue was up 59.4% on a year-over-year basis. On average, equities analysts forecast that Axcelis Technologies, Inc. will post $1.25 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Metropolitan Life Insurance Co. NY Has $387,000 Position in Axcelis Technologies, Inc. (ACLS)” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://www.com-unik.info/2017/08/18/metropolitan-life-insurance-co-ny-has-387000-position-in-axcelis-technologies-inc-acls.html.

ACLS has been the topic of several recent analyst reports. Zacks Investment Research raised shares of Axcelis Technologies from a “hold” rating to a “strong-buy” rating and set a $22.00 target price on the stock in a research note on Wednesday, May 3rd. B. Riley reaffirmed a “buy” rating and issued a $30.00 price target on shares of Axcelis Technologies in a research note on Friday, May 5th. Benchmark Co. reissued a “buy” rating and set a $24.00 target price (up from $21.00) on shares of Axcelis Technologies in a research report on Friday, May 5th. Needham & Company LLC reissued a “buy” rating and set a $23.00 target price (up from $20.00) on shares of Axcelis Technologies in a research report on Friday, May 5th. Finally, Stifel Nicolaus decreased their price target on shares of Axcelis Technologies from $19.00 to $16.00 and set a “hold” rating for the company in a report on Friday, May 5th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $24.67.

In related news, CFO Kevin J. Brewer sold 93,750 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $21.94, for a total transaction of $2,056,875.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Douglas A. Lawson sold 14,454 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $21.12, for a total transaction of $305,268.48. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 254,454 shares of company stock valued at $5,806,106. 5.66% of the stock is currently owned by insiders.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services and customer training.

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS).

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

What are top analysts saying about Axcelis Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Axcelis Technologies Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit